Establishment Labs
- Country
- Ownership
- -
- Employees
- 908
- Market Cap
- -
- Introduction
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.
Establishment Labs Gains FDA Approval for Motiva Breast Implants
• Establishment Labs has received FDA approval for its Motiva SmoothSilk Ergonomix and Round breast implants for primary and revision augmentation.
• The Motiva implants feature a patented SmoothSilk surface, designed to enhance biocompatibility and promote low inflammation.
• Clinical trials showed less than 1% rates of capsular contracture and rupture with Motiva implants, demonstrating their safety and effectiveness.
• Nearly four million Motiva devices have been delivered globally since 2010, marking a significant milestone for Establishment Labs.
© Copyright 2025. All Rights Reserved by MedPath